Boston Scientific Corp- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 Boston Scientific Corp 公司

波士頓科學公司是一家全球醫療器械開發商、製造商和營銷商，其產品用於一系列介入醫學專業。其 MedSurg 部門包括內窺鏡檢查、泌尿科和神經調節。其內窺鏡業務開發和製造用於診斷和治療各種胃腸道 (GI) 和肺部疾病的設備，採用微創技術。其泌尿科業務開發和製造用於治療男性和女性各種泌尿系統疾病的設備。其神經調節業務開發和製造用於治療各種神經運動障礙和控制慢性疼痛的設備。其心血管部門包括心臟病學和外周介入。其介入心臟病學治療業務開發和製造用於診斷和治療冠狀動脈疾病和主動脈瓣疾病的技術。該公司還擁有經頸動脈血運重建 (TCAR) 平臺。

Boston Scientific Corp簡介



公司代碼BSX

公司名稱Boston Scientific Corp

上市日期May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

員工數量53000

證券類型Ordinary Share

年結日May 19

公司地址300 Boston Scientific Way

城市MARLBOROUGH

上市交易所NYSE Consolidated

國家United States of America

郵編01752-1234

電話15086834000

網址https://www.bostonscientific.com/en-US/Home.html

公司代碼BSX

上市日期May 19, 1992

CEOMr. Michael F. (Mike) Mahoney

Boston Scientific Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

Mr. David C. Habiger

Independent Director

5.63K

+58.67%

Mr. Yoshiaki Fujimori

Independent Director

2.08K

-58.23%

Mr. Arthur Crosswell Butcher

Executive Vice President, Group President, MedSurg and Asia Pacific

--

Mr. Edward J. Ludwig

Lead Independent Director

--

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael F. (Mike) Mahoney

Chairman of the Board, President, Chief Executive Officer

1.75M

-3.25%

Mr. John E. Sununu

Independent Director

54.72K

+3.95%

Mr. David S. (Dave) Wichmann

Independent Director

41.58K

+5.27%

Mr. Jonathan R. Monson

Chief Financial Officer, Executive Vice President

35.29K

+1.62%

Mr. Vance R. Brown

Senior Vice President, General Counsel, Corporate Secretary

33.45K

+6.64%

Ms. Ellen M. Zane

Independent Director

24.13K

-34.82%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

地區USD

名稱

營收

佔比

United States

3.22B

63.70%

EMEA (Europe, Middle East and Africa)

878.00M

17.35%

Asia Pacific

790.00M

15.61%

Latin America and Canada

169.00M

3.34%

業務

地區

業務USD

名稱

營收

佔比

Electrophysiology

840.00M

16.60%

Endoscopy

737.00M

14.56%

Interventional Cardiology Therapies

731.00M

14.44%

Peripheral Interventions

698.00M

13.79%

Urology

676.00M

13.36%

其他

1.38B

27.25%

股東統計

更新時間: 11月8日週六

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

持股股東

佔比

The Vanguard Group, Inc.

9.28%

Fidelity Management & Research Company LLC

6.11%

BlackRock Institutional Trust Company, N.A.

5.37%

State Street Investment Management (US)

4.38%

PRIMECAP Management Company

2.23%

其他

72.63%

股東類型

持股股東

佔比

Investment Advisor

50.65%

Investment Advisor/Hedge Fund

30.26%

Hedge Fund

4.19%

Pension Fund

2.92%

Research Firm

2.44%

Bank and Trust

1.87%

Sovereign Wealth Fund

1.54%

Family Office

0.23%

Private Equity

0.21%

其他

5.69%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

2840

1.40B

94.18%

+558.00K

2025Q2

2752

1.39B

93.57%

+165.36K

2025Q1

2744

1.39B

93.81%

-5.31M

2024Q4

2559

1.38B

93.61%

+1.09M

2024Q3

2417

1.37B

92.76%

-24.32M

2024Q2

2341

1.37B

93.29%

-18.17M

2024Q1

2227

1.37B

93.23%

-40.14M

2023Q4

2171

1.39B

94.95%

-25.34M

2023Q3

2110

1.39B

95.17%

-6.29M

2023Q2

2081

1.38B

95.67%

-15.63M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

136.47M

9.21%

+2.53M

+1.89%

Jun 30, 2025

Fidelity Management & Research Company LLC

99.47M

6.71%

-17.98M

-15.31%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

78.19M

5.28%

+380.40K

+0.49%

Jun 30, 2025

State Street Investment Management (US)

65.19M

4.4%

+713.38K

+1.11%

Jun 30, 2025

PRIMECAP Management Company

34.66M

2.34%

-1.83M

-5.03%

Jun 30, 2025

Geode Capital Management, L.L.C.

32.42M

2.19%

+622.60K

+1.96%

Jun 30, 2025

Capital World Investors

28.52M

1.93%

-33.95K

-0.12%

Jun 30, 2025

Managed Account Advisors LLC

22.05M

1.49%

+765.61K

+3.60%

Jun 30, 2025

The Bollard Group, LLC

20.08M

1.36%

-411.38K

-2.01%

Jun 30, 2025

Norges Bank Investment Management (NBIM)

19.46M

1.31%

-275.11K

-1.39%

Jun 30, 2025

持股ETF



更新時間: 11月6日週四

機構名稱

佔比

iShares U.S. Medical Devices ETF

11.98%

Goldman Sachs Future Health Care Equity ETF

7.69%

Invesco Dorsey Wright Healthcare Momentum ETF

4.06%

JPMorgan Healthcare Leaders ETF

3.67%

Tema Heart & Health ETF

3.64%

Segall Bryant & Hamill Select Equity ETF

3.46%

Parnassus Core Select ETF

2.95%

Health Care Select Sector SPDR Fund

2.87%

Proshares Ultra Health Care

2.86%

Knowledge Leaders Developed World ETF

2.85%

iShares U.S. Medical Devices ETF

佔比11.98%

Goldman Sachs Future Health Care Equity ETF

佔比7.69%

Invesco Dorsey Wright Healthcare Momentum ETF

佔比4.06%

JPMorgan Healthcare Leaders ETF

佔比3.67%

Tema Heart & Health ETF

佔比3.64%

Segall Bryant & Hamill Select Equity ETF

佔比3.46%

Parnassus Core Select ETF

佔比2.95%

Health Care Select Sector SPDR Fund

佔比2.87%

Proshares Ultra Health Care

佔比2.86%

Knowledge Leaders Developed World ETF

佔比2.85%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據